Please try another search
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company’s products portfolio comprises bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Incheon, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Byung-In Lee | 59 | - | Head of Business Operation Division and Director |
Young-Cheol Son | 60 | - | Head of Management Support Division and Director |
Jung-Won Seo | 62 | - | Head of Bio Processing Division and Director |
Jung-Jin Lee | 60 | - | Head of Bio-Tech Research Center and Director |
Baek-Cheon Lee | 82 | - | Chairman |
Won-Seok Kim | 61 | - | Head of Production Division and Director |
Myung-Ho Jeon | 52 | - | Director |
Woo-Jib Kim | - | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review